$Abstract: Topical 0.5% Timolol for Chronic Refractory Wounds. an Observational Prospective Study$

Abstract: Topical 0.5% Timolol for Chronic Refractory Wounds. an Observational Prospective Study

Bibliographic Details
Main Authors:	Michelangelo Vestita, MD, Angela Filoni, MD, Domenico Bonamonte, MD, PhD, Paolo Annoscia, MD, Giuseppe Giudice, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2017-09-01
Series:	Plastic and Reconstructive Surgery, Global Open
Online Access:	http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526190.20003.08

Similar Items

Abstract: Efficacy, Safety and Costs of 0.1% Timolol Gel in Healing Split-Thickness Skin Grafts Donor Sites. A Case-Control Study
by: Michelangelo Vestita, MD, et al.
Published: (2017-09-01)

Abstract: The Use of Nanofat in Androgenic Alopecia. a Prospective Blinded Study
by: Michelangelo Vestita, MD, et al.
Published: (2017-09-01)

Abstract: “Facial Regeneration” By Nanofat. A Randomized Case-Control Study
by: Michelangelo Vestita, MD, et al.
Published: (2018-09-01)

Abstract: 595nm Pulsed Dye Laser for Hypetrophic and Keloid Scars Treatment. a Randomized-Controlled Study
by: Michelangelo Vestita, MD, et al.
Published: (2017-09-01)

Abstract: The Association of Nexobrid, Nanofat and 0.1%Timolol Gel Vs Standard of Care in Venous Leg Ulcers Management. A Multicenter Trial
by: Michelangelo Vestita, MD, et al.
Published: (2018-09-01)

Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds
by: Giuseppe Giudice, et al.
Published: (2017-01-01)

Abstract: Nanofat+Prp Vs Prp in Androgenic Alopecia. An Intra-Patient Case-Control Study
by: Michelangelo Vestita, MD, et al.
Published: (2018-09-01)

Abstract: Efficacy and Safety of the Stromal Vascular Fraction in Intermediate-Deep Burns. a Randomized Controlled Pilot Study
by: Michelangelo Vestita, MD, et al.
Published: (2017-09-01)

Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%)
by: Moataz E Gheith, et al.
Published: (2008-03-01)

Abstract: Multiple Lymphaticovenular Anastomoses in Preventing Lymphedema Following Complete Lymph Node Dissection in Melanoma Patients
by: Michelangelo Vestita, MD, et al.
Published: (2018-09-01)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
by: Hai Wei Wu, et al.
Published: (2017-06-01)

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
by: Anne J Lee, et al.
Published: (2008-10-01)

Case Report: “Incognito” proteus syndrome [version 1; referees: 2 approved]
by: Michelangelo Vestita, et al.
Published: (2018-02-01)

Vitamin D and Atopic Dermatitis in Childhood
by: Michelangelo Vestita, et al.
Published: (2015-01-01)

Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
by: Costa VP, et al.
Published: (2012-05-01)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
by: Schnober D, et al.
Published: (2015-05-01)

The Role of the Environmental Risk Factors in the Pathogenesis and Clinical Outcome of Atopic Dermatitis
by: Domenico Bonamonte, et al.
Published: (2019-01-01)

A Comparison of Ocular Hypotensive Response to Betaxolol and Timolol And Their Topical and Systemic Side Effects
by: M. Samavati, M.D
Published: (2007-09-01)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
by: Inoue K, et al.
Published: (2015-04-01)

Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: A prospective, single-arm study
by: Hrishabh Jaiswal, et al.
Published: (2021-01-01)

Comparison of conjunctival impression cytology between glaucoma patients treated with topical timolol maleate 0.5% and topicallatanoprost 0.005%.
by: Hitam, Wan Hazabbah Wan, et al.
Published: (2004)

Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study
by: Kumar Harsh, et al.
Published: (2002-01-01)

Fractional erbium-doped yttrium aluminum garnet laser 2940 nm-assisted delivery of topical timolol solution for the treatment of histiocytoid hemangioma
by: Mohammed Albeshri, MD, et al.
Published: (2021-03-01)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
by: Baiza-Dur&aacute;n LM, et al.
Published: (2012-07-01)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
by: Kanamoto T, et al.
Published: (2012-03-01)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
by: Shimizu Y, et al.
Published: (2015-03-01)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
by: Douglas J Rhee, et al.
Published: (2008-06-01)

Topical timolol and lipid profile
by: Manoher J, et al.
Published: (1995-01-01)

Dual plane breast implant reconstruction in large sized breasts: How to maximise the result following first stage total submuscular expansion
by: Giuseppe Giudice, et al.
Published: (2018-03-01)

Skin Reactions to Pine Processionary Caterpillar Thaumetopoea pityocampa Schiff
by: Domenico Bonamonte, et al.
Published: (2013-01-01)

Abstract: The Use of Negative Pressure Wound Therapy in Skin-Containing Free Tissue Transfer
by: Mija Khan, MD, et al.
Published: (2017-09-01)

Comparação do volume da gota e custo do tratamento dos genéricos de maleato de timolol 0,5% Drop volume and cost of treatment with generic 0.5% timolol maleate preparations
by: João Antonio Prata Junior, et al.
Published: (2004-06-01)

Abstract: Enhanced Wound Healing By Treatment with Heat Stable Antigen (HSA/CD24)
by: Or Friedman, MD, et al.
Published: (2017-09-01)

Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice
by: Pfennigsdorf S, et al.
Published: (2016-09-01)

The Efficacy of Different Ropivacaine Concentrations (0.5%, 0.6% vs 0.75%) for Regional Nerve Block in Lower Extremity
by: Chan Kang MD, et al.
Published: (2018-09-01)

Brinzolamide-timolol suspension: acceptability and side effect profile
by: Doherty MD, et al.
Published: (2011-03-01)

Abstract 168: Effect Of Nitric Oxide Releasing Gel On Excisional Wound Healing
by: Chikage noishiki, MD, PhD, et al.
Published: (2020-04-01)

Abstract 23: Immediate Reconstruction of Oncologic Spinal Wounds Is Cost Effective Compared to Conventional Primary Wound Closure
by: Alexander F. Mericli, M.D., et al.
Published: (2019-04-01)

Abstract 108: Dehydrated Amniotic Membrane Allograft Promotes Healing Of Complex Wounds
by: Melody Bedrossian, BS, et al.
Published: (2020-04-01)